MUC1 and breast carcinoma: CA 15-3 is a transmembrane glycoprotein of a serum-based derivative of the MUC1 gene and is the most extensively utilized biomarker in observing progressive breast cancer cases that overproduce CA 15-3 in response to chemotherapy [25], and it is commonly expressed through breast cells.